1-5 of 5
Hong Xie
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Chemotherapy Delay on Overall Survival for AML with I DH1/2 Mutations: A Study in Adult Chinese Patients

Jing Han Wang, PhDMD, Qi Guo, Zhi Xin Ma, Qiu Ling Ma, Meng Xia Yu, Xiu Feng Yin, Sha Sha Lu, Qiong Hong Xie, Yue Hong Jiang, Dan Shen, li Ya Ma, Hui Shi, Wen Juan Yu, Ye Jiang Lou, Ying Li, Min Yang, Gai Xiang Xu, Li Ping Mao, Jian Hu Li, Fan Ping Wang, Dong Mei Wang, Ju Ying Wei, Hong Yan Tong, Jian Huang, Jie Jin, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4905.
https://doi.org/10.1182/blood.V126.23.4905.4905
Published: 2015
Journal Articles

Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti–IL-6) in multiple myeloma

Clinical Trials & Observations
Jesús San-Miguel, Joan Bladé, Ofer Shpilberg, Sebastian Grosicki, Frédéric Maloisel, Chang-Ki Min, Marta Polo Zarzuela, Tadeusz Robak, Sripada V. S. S. Prasad, Yeow Tee Goh, Jacob Laubach, Andrew Spencer, María-Victoria Mateos, Antonio Palumbo, Tom Puchalski, Manjula Reddy, Clarissa Uhlar, Xiang Qin, Helgi van de Velde, Hong Xie, Robert Z. Orlowski
Journal: Blood
Blood (2014) 123 (26): 4136–4142.
https://doi.org/10.1182/blood-2013-12-546374
Published: 2014
Journal Articles

A Phase 2 Multicenter Study of Siltuximab, An Anti-IL-6 Monoclonal Antibody, in Patients with Relapsed or Refractory Multiple Myeloma,

Peter M. Voorhees, MD, Robert F Manges, MD, Pieter Sonneveld, MD, PhD, Sundar Jagannath, MD, George Somlo, MD, Amrita Krishnan, MD, Suzanne Lentzsch, MD, PhD, Richard C Frank, MD, Sonja Zweegman, MD, PhD, P.W. Wijermans, MD, PhD, Britte Rijnbeek, Xiang Qin, PhD, Mark J. Cornfeld, MD, MPH, Hong Xie, MD, MS, MBA, Sheeba K. Thomas, MD
Journal: Blood
Blood (2011) 118 (21): 3971.
https://doi.org/10.1182/blood.V118.21.3971.3971
Published: 2011
Journal Articles

Inhibition of Interleukin-6 Signaling with CNTO 328 Sensitizes Plasma Cell Dyscrasias to the Effects of Melphalan in Association with Suppression of Signaling through Protein Kinase B/Akt.

Sally A. Hunsucker, Ph.D., Valeria Magarotto, M.D., Jairo A. Matthews, B.A., Michael Wang, M.D., Veerabhadran Baladandayuthapani, Ph.D., Peter M. Voorhees, M.D., Hong Xie, M.D., Mark Cornfeld, M.D., M.P.H., Jeffrey A. Nemeth, M.D., Ph.D., Robert Z. Orlowski, M.D., Ph.D.
Journal: Blood
Blood (2009) 114 (22): 1836.
https://doi.org/10.1182/blood.V114.22.1836.1836
Published: 2009
Journal Articles

Preliminary Results of CNTO 328, An Anti-Interleukin-6 Monoclonal Antibody, in Combination with Bortezomib in the Treatment of Relapsed or Refractory Multiple Myeloma

Jean-Francois Rossi, MD, PhD, Robert F. Manges, MD, Heather J. Sutherland, MD, PhD, Sundar Jagannath, MD, Peter Voorhees, MD, Pieter Sonneveld, MD, Michel Delforge, MD, PhD, Brigitte Pegourie, MD, Adrian Alegre, MD, Javier de la Rubia, MD, David La Police, BS, Rajesh Bandekar, PhD, Hong Xie, MD, Robert Z. Orlowski, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 867.
https://doi.org/10.1182/blood.V112.11.867.867
Published: 2008